This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Real validated RBX1 Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-RBX1 WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~12.3 kDa | |
| Observed band | Approximately 15 kDa | |
| Gel | 12–15% | |
| Negative control | siRNA / KO lysate |
| PTM | Phosphorylated + Acetylated | |
| Caveat | Phosphorylation-induced mobility shift | |
| Regulation | Dna repair | |
| Isoform | 1 isoform(s) |
Literature-validated Western blot parameters for RBX1 — gel percentage, transfer, blocking, antibody incubation and detection, extracted from published methods.
| Sample / lysate | Rat Testis , Lane 2: Rat Brain , Lane 3: Mouse Brain , Lane 4: Mouse Spleen . After electrophoresis, proteins were transferred to a nitrocellulose membrane at 150 mA for 50-90 minutes. Blocked the membrane with 5% non-fat milk/TBS for 1.5 hour at RT. The membrane was incubated with rabbit anti-ROC1 antigen affinity purified polyclonal antibody (Catalog # PB9798) at 0.5 μg/mL overnight at 4°C, then washed with TBS-0.1%Tween 3 times with 5 minutes each and probed with a goat anti-rabbit IgG-HRP secondary antibody at a dilution of 1:5000 for 1.5 hour at RT. The signal is developed using an Enhanced Chemiluminescent detection (ECL) kit (Catalog # EK1002) with Tanon 5200 system. A specific band was detected for ROC1 at approximately 15 kDa. The expected band size for ROC1 is at 15 kDa |
| Gel % | 12–15% |
| Load | 50 ug |
| Transfer | nitrocellulose membrane, 150 mA, 50–90 min |
| Membrane | nitrocellulose |
| Blocking | 5% non-fat milk / TBS, 1.5 h RT |
| Primary antibody | 0.5 µg/mL |
| Primary incubation | overnight at 4 °C |
| Secondary antibody | goat anti-rabbit IgG-HRP, 1:5000 |
| Wash | TBS-0.1% Tween, 3 × 5 min |
| Detection | ECL |
| Exposure / imaging | Tanon 5200 |
| Observed band | 15 kDa |
RBX1 has a 12.3 kDa predicted mass but typically runs near 15 kDa on Western blots, likely due to anomalous SDS-PAGE migration of its compact zinc-finger RING domain.
| single band around 15 kDa | represents the full-length RBX1 monomer, migrating somewhat above its 12.3 kDa predicted mass |
| no higher-mass smeared band | RBX1 has no annotated glycosylation sites, so carbohydrate-driven smearing is not expected |
| no shift in band position under non-reducing conditions | RBX1 has no annotated disulfide bonds, so it does not form a covalent homodimer |
| one band rather than several close-migrating bands | only a single isoform is annotated for RBX1, so isoform-driven multi-banding is not expected |
| band detectable in standard cytoplasmic/whole-cell lysate | RBX1 is cytoplasmic and nuclear, not secreted, so it should be present in routine lysates rather than absent from them |
| band running noticeably above the 12.3 kDa predicted mass | the compact, zinc-coordinated RING domain of RBX1 favors anomalous, slower-than-predicted migration on SDS-PAGE |
| predicted mass (12.3 kDa) | sets the theoretical baseline, but the actual monomer typically runs somewhat higher, near 15 kDa |
| RING-type zinc-finger / metal-binding domain | compact zinc-coordinated folds resist full unfolding in SDS-PAGE and commonly cause slower-than-predicted migration, contributing to the ~15 kDa apparent size |
| N-terminal acetylation and processing (Met1/Ala2) | adds negligible mass but marks the mature processed N-terminus of the monomer |
| phosphorylation at Thr9 | adds negligible mass but can slightly alter charge-driven mobility |
| absence of glycosylation sites | rules out any smearing or upward mass shift from carbohydrate addition |
| absence of disulfide bonds | means RBX1 runs as a monomer rather than doubling in size as a covalent homodimer under non-reducing conditions |
| single annotated isoform | means only one specific band is expected, not multiple isoform-driven bands |
| non-covalent SCF complex membership (CUL1-SKP1-RBX1-F-box) | the complex dissociates under denaturing/reducing SDS-PAGE, so only the free ~15 kDa RBX1 monomer band should appear rather than a higher-mass complex band |
| Situation | Likely cause | Next action |
|---|---|---|
| Band higher than expected | the compact zinc-finger RING domain retains residual structure and migrates anomalously slower than its predicted mass | increase reducing agent and heat-denaturation time, and run a known RBX1 standard alongside for comparison |
| Band lower than expected | the very small predicted size (12.3 kDa) can run off standard gels or transfer through the membrane before proper resolution | use a higher-percentage gel (15-18%) or a low-molecular-weight-optimized system and shorten transfer time |
| Weak or no signal | small proteins like RBX1 can blow through the membrane during standard transfer conditions | reduce transfer voltage or time, use a low pore-size PVDF membrane, and confirm against a positive control lysate |
| Multiple bands | cross-reactivity with other RING/zinc-finger subunits of the SCF complex or incomplete dissociation of RBX1 from CUL1/SKP1 | verify specificity with an RBX1 knockdown lysate and ensure complete denaturation with SDS and heat before loading |
| Fragments below expected size | as a small single-domain protein, RBX1 is susceptible to proteolytic degradation during lysate handling | prepare lysates fresh with protease inhibitors and keep samples cold throughout processing |
| No band in lysate | insufficient loading or antibody sensitivity for a low-abundance, low-molecular-weight regulatory subunit | increase total protein loaded, use a high-sensitivity chemiluminescent substrate, and confirm with a cell line known to express RBX1 |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|
| Tissue | Cell type | Level | Evidence | Source |
|---|
Deeper troubleshooting and optimisation questions for RBX1, answered from its protein features.
BosterBio's RBX1 antibodies are among the best-performing WB antibodies on the market — well cited, thoroughly validated, and orthogonally cross-validated against negative tissues and complementary methods.
The anti-RBX1 antibodies below represent our top-performing picks for Western blot, selected for strong literature citation, rigorous in-house validation, and cross-validation against negative-control tissues and orthogonal methods—giving you confident, reproducible detection of RBX1 in your samples.
Which to pick: Only one Boster RBX1 antibody is catalogued, PB9798, which includes an actual Western blot validation image confirming specific detection—making it the clear default choice for your RBX1 WB experiments; no alternative SKUs are available to compare against.